US gov­ern­ment more than dou­bles the sup­ply of mon­key­pox vac­cine

HHS on Fri­day bought 2.5 mil­lion more dos­es of Bavar­i­an Nordic’s Jyn­neos, an FDA-li­censed vac­cine that’s help­ing to stave off this cur­rent and po­ten­tial­ly fu­ture mon­key­pox out­breaks.

The or­der brings the to­tal vac­cine dos­es to be de­liv­ered in 2022 and 2023 to 4.4 mil­lion, but Bavar­i­an said in a state­ment that de­liv­er­ies un­der this con­tract won’t start un­til Q4 of 2022, and will con­tin­ue through ear­ly 2023. Bavar­i­an al­so said that “the ma­jor­i­ty of the dos­es un­der this con­tract are planned for de­liv­ery in 2023” so it won’t have any ef­fect on the com­pa­ny’s fi­nan­cial guid­ance this year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER